Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05020951 · ClinicalTrials.gov registry record
Pilot Study to Enable Electronic Laboratory Data Transfer From Participating Institutions to MediData/RAVE
A clinical trial of Accurate and Complete Data Acquisition for Clinical Trials, sponsored by Children's Oncology Group.
- Active
- Registry status
- 118
- Enrollment target
- 8
- Study locations
NCT05020951: Active study of Accurate and Complete Data Acquisition for Clinical Trials, sponsored by Children's Oncology Group.
NCT05020951 is a study of Accurate and Complete Data Acquisition for Clinical Trials that is active but no longer recruiting, run by Children's Oncology Group. The registered enrollment target is 118 participants. The trial reports 8 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05020951, a study of Accurate and Complete Data Acquisition for Clinical Trials, is active but no longer recruiting, sponsored by Children's Oncology Group.
- ACTIVE NOT RECRUITING
- Registry status
- 118 participants
- Enrollment target
- 8
- Study locations
Study Summary
An initial step toward more accurate and complete data acquisition for clinical trials, the Pediatric Early Phase Clinical Trials Network (PEP-CTN) and Pediatric Brain Tumor Consortium (PBTC) will assess the feasibility of electronic transfer of laboratory data from participating institutions' local electronic health records to the Medidata/RAVE that is housed within each consortium's Uniform Resource Locator (URL). This study will assess efficiency, effectiveness, and scalability of the laboratory data extraction and transfer processes. This study will identify factors in the process that impact consortium operations, central protocol activation and implementation to the point of declaring the site data-ready.
Primary Outcome
Thorough evaluation of the data extraction and transfer process from each participating site to the PBTC and PEP-CTN databases. Establish feasibility of the proposed process at each site as well as the operations cores.
Conditions Studied
Interventions
- OTHER Medidata RAVE
Study Locations (8)
Georgia
- Children's Healthcare of Atlanta - Egleston - Atlanta
- Children's Healthcare of Atlanta - Atlanta
California
- UCSF Medical Center-Mission Bay - San Francisco
New York
- Memorial Sloan Kettering Cancer Center - New York
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Tennessee
- Saint Jude Children's Research Hospital - Memphis
Texas
- Texas Children's Hospital - Houston
Washington
- Seattle Children's Hospital - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2021-08-28 |
| Est. Completion | 2026-03-31 |
What the registry record for NCT05020951 still lists
NCT05020951 is an observational study that tracks outcomes without assigning an intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Accurate and Complete Data Acquisition for Clinical Trials appearing as the primary indexed condition, and to 1 intervention - of which Medidata RAVE is the first listed.
NCT05020951 lists 8 locations in 7 states (Georgia, California, New York).
Frequently Asked Questions
What is clinical trial NCT05020951 about?
NCT05020951 is a clinical study titled "Pilot Study to Enable Electronic Laboratory Data Transfer From Participating Institutions to MediData/RAVE". An initial step toward more accurate and complete data acquisition for clinical trials, the Pediatric Early Phase Clinical Trials Network (PEP-CTN) and Pediatric Brain Tumor Consortium (PBTC) will assess the feasibility of electronic transfer of laboratory data from participating institutions' local...
What is the current status of trial NCT05020951?
This trial is currently active not recruiting. The enrollment target is 118 participants. The study started on 2021-08-28. Estimated completion is 2026-03-31.
What conditions does trial NCT05020951 study?
This clinical trial studies the following conditions: Accurate and Complete Data Acquisition for Clinical Trials.
What interventions are being tested in trial NCT05020951?
The interventions under investigation include: Medidata RAVE (OTHER).
Who is sponsoring clinical trial NCT05020951?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05020951 being conducted?
This trial has 8 study locations across California, Georgia, New York, Pennsylvania, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03821623 · 118 participants · Phase 2
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
- NCT04040959 · 118 participants · Phase 2
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
- NCT04696029 · 118 participants · Phase 2
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- NCT05223192 · 118 participants · NA
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI